Source link : https://www.newshealth.biz/health-news/ai-model-has-promise-for-predicting-checkpoint-inhibitor-activity-in-nsclc/
Artificial intelligence (AI)-aided analysis of pathology slides showed potential as a predictive biomarker for non-small cell lung cancer (NSCLC) response to immune checkpoint inhibitors (ICIs), a multicenter study showed. The deep-learning model (called Deep-IO) achieved an area under the receiver operating characteristic curve (AUC) of 0.75 for objective response in a U.S.-based developmental cohort and […]
Author : News Health
Publish date : 2024-12-27 21:57:52
Copyright for syndicated content belongs to the linked Source.